Lixte Biotechnology Holdings Inc (LIXTW) — Net Asset Quality Index
Lixte Biotechnology Holdings Inc (LIXTW) has a Net Asset Quality Index of 90.4% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $5.43 Million minus total liabilities of $521.42K yields net assets of $4.91 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Lixte Biotechnology Holdings Inc for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Lixte Biotechnology Holdings Inc Net Asset Quality Index Over Time (2005–2024)
This chart shows how Lixte Biotechnology Holdings Inc's Net Asset Quality Index has evolved across 20 annual periods from 2005 to 2024. As of September 2025, the index stands at 90.4%, representing net assets of $4.91 Million against total assets of $5.43 Million USD. For live market cap and overall valuation, see LIXTW market cap overview.
Annual Net Asset Quality Index for Lixte Biotechnology Holdings Inc (2005–2024)
The table below presents the year-by-year Net Asset Quality Index for Lixte Biotechnology Holdings Inc from 2005 to 2024, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Lixte Biotechnology Holdings Inc net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 72.2% | $827.22K | $1.15 Million | $318.28K | ▼ -20.5 pp |
| 2023 | 92.7% | $3.99 Million | $4.31 Million | $313.86K | ▼ -0.2 pp |
| 2022 | 92.9% | $5.17 Million | $5.56 Million | $394.79K | ▼ -1.2 pp |
| 2021 | 94.1% | $4.79 Million | $5.09 Million | $302.93K | ▼ -1.8 pp |
| 2020 | 95.9% | $5.01 Million | $5.23 Million | $216.52K | ▲ +4.8 pp |
| 2019 | 91.1% | $2.43 Million | $2.67 Million | $237.90K | ▼ -4.0 pp |
| 2018 | 95.1% | $4.13 Million | $4.34 Million | $210.91K | ▲ +22.4 pp |
| 2017 | 72.7% | $995.04K | $1.37 Million | $373.02K | ▲ +23.2 pp |
| 2016 | 49.6% | $214.76K | $433.41K | $218.65K | ▼ -2.7 pp |
| 2015 | 52.2% | $312.33K | $597.98K | $285.64K | ▲ +2.9 pp |
| 2014 | 49.3% | $265.86K | $539.30K | $273.44K | ▲ +7.0 pp |
| 2013 | 42.3% | $236.27K | $558.04K | $321.77K | ▼ -42.8 pp |
| 2012 | 85.1% | $1.49 Million | $1.75 Million | $261.15K | ▲ +66.7 pp |
| 2011 | 18.4% | $79.02K | $429.77K | $350.75K | ▼ -71.5 pp |
| 2010 | 89.9% | $1.74 Million | $1.93 Million | $195.06K | ▲ +8.7 pp |
| 2009 | 81.2% | $1.30 Million | $1.60 Million | $300.26K | ▲ +707.6 pp |
| 2008 | -626.4% | $-323.55K | $51.65K | $375.20K | ▼ -686.3 pp |
| 2007 | 59.9% | $376.93K | $629.11K | $252.18K | ▼ -23.5 pp |
| 2006 | 83.4% | $626.56K | $751.07K | $124.50K | ▲ +253.3 pp |
| 2005 | -169.9% | $-7.87K | $4.63K | $12.50K | — |